Dr. Tim J. Whelan from Juravinski Cancer Centre Provides a MA.20 Trial Result Summary
Timothy J. Whelan, BM, BCh
Advertisement
Articles by Timothy J. Whelan, BM, BCh
Dr. Tim J. Whelan from Juravinski Cancer Centre on the Percentage the MA.20 Trial Benefits
Dr. Timothy J. Whelan from Juravinski Cancer Centre Discusses the MA.20 Trial's Survival Findings
Advertisement
Latest Updated Articles
Dr. Whelan Discusses the MA.20 Trial's Survival FindingsPublished: July 8th 2011 | Updated:
Dr. Whelan on the Women the MA.20 Trial BenefitsPublished: July 11th 2011 | Updated:
Dr. Whelan Provides a MA.20 Trial Result SummaryPublished: July 14th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
4
Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP
5